Purification specialist BIA Separations to become part of Sartorius

BIA Separations will be Sartorius’ center of excellence for purification of cell and gene therapeutics

05-Oct-2020 - Sartorius announced it has entered into a definitive agreement to merge purification specialist BIA Separations into its subgroup Sartorius Stedim Biotech in a transaction totaling 360 million euros of which 240 million euros will be paid in cash and 120 million euros in Sartorius Stedim Biotech ...

BIA Separations Expands with New Upstream Processing Facility

Investment in new lab will support integrated optimisation of upstream and downstream process development

18-Sep-2018 - BIA Separations announced the expansion of its services with the opening of a new upstream processing (USP) laboratory. The investment in the new facility comes in response to customer demand for services that optimise the critical interface between upstream and downstream processing for the ...

Plasmid DNA manufacturing technology - development of Boehringer Ingelheim with BIA Separations

16-Mar-2005 - Boehringer Ingelheim Austria GmbH and BIA Separations d.o.o. announced technological innovation in the field of plasmid DNA (pDNA) manufacture. In order to meet the growing need for pharmaceutical grade pDNA, Boehringer Ingelheim Austria has developed high cell density fermentation technology ...